Source: International homepage (paywall)
As weight-loss drug users cut calories and reshape their bodies, entire categories face demand collapse. Food delivery, casual dining, and snack manufacturers are seeing real revenue pressure while gyms, dermatology, and luxury goods are capturing the freed-up spending. Millions of consumers are literally consuming less of the products that built consumer capitalism, forcing CPG companies to either reformulate for portion control or retarget their marketing toward the non-medicated majority. The businesses that win will treat GLP-1 adoption as a lasting demographic segmentation tool, not a temporary fad to weather.